Sustained outcomes in oral immunotherapy for peanut allergy
Oct 19, 2019 · We evaluated the sustained effects of peanut allergy oral immunotherapy (OIT) in a randomised long-term study in adults and children.
Long-Term Follow-up after IMPACT Peanut Oral Immunotherapy …
The IMPACT trial (NCT01867671) demonstrated strong desensitization and the potential for remission with peanut oral immunotherapy (OIT) in 1–4-year-olds. Data on long-term …
760410 | Stanford Health Care
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Dietary avoidance is …
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
The proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral Immunotherapy …
Few people with peanut allergy tolerate peanut after stopping …
Sep 13, 2019 · Investigators at Stanford University enrolled 120 people aged 7 to 55 with diagnosed peanut allergy in the Peanut Oral Immunotherapy Study: Safety Efficacy and …
870971 | Stanford Health Care
Aside from peanut avoidance and symptom management, oral immunotherapy (OIT) is another option for PA patients. However, OIT can be associated with adverse events and pose safety …
We evaluated the sustained efects of peanut allergy oral immunotherapy (OIT) in a randomised long-term study in adults and children.
Sustained Outcomes in a Large Double-blind, Placebo-controlled ...
We evaluated sustained effects of peanut allergy oral immunotherapy (OIT) in the first randomized long-term study in adults and children. Peanut allergic participants (7–55 years-old) underwent ...
Few people with peanut allergy tolerate peanut after stopping …
Sep 13, 2019 · Investigators at Stanford University enrolled 120 people aged 7 to 55 with diagnosed peanut allergy in the Peanut Oral Immunotherapy Study: Safety Efficacy and …
Peanut Oral Immunotherapy in Children - Stanford Health Care
This is a randomized, double-blind, placebo-controlled, multi-center study comparing peanut oral immunotherapy (OIT) to placebo in the induction of tolerance and desensitization in peanut …